Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS)

125 filings reported holding ACRS - Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q1 2025.
Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92,164,636 shares of 108,380,780 outstanding shares and own 85% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (14,250,000 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (9,627,304 shares), Vivo Capital, LLC (8,888,888 shares), Rock Springs Capital Management LP (5,046,309 shares), VANGUARD GROUP INC (4,970,254 shares), RA CAPITAL MANAGEMENT, L.P. (4,666,667 shares), MILLENNIUM MANAGEMENT LLC (4,134,148 shares), Decheng Capital LLC (4,041,736 shares), D. E. Shaw & Co., Inc. (2,944,512 shares), and MORGAN STANLEY (2,415,584 shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.